News & events Upcoming events Eurogin 2019 Dec 4, 2019 - Dec 7, 2019 Monaco , Monaco More info and meet us there CTAD Alzheimer - 12th Clinical Trials on Alzheimer's Disease Dec 4, 2019 - Dec 7, 2019 San Diego, CA , United States More info and meet us there APCON 2019 Dec 5, 2019 - Dec 8, 2019 Chandigarh , India More info and meet us there See all upcoming events Latest news Fujirebio Europe N.V. signs distribution agreement and extends its molecular product portfolio with the Atila Biosystems, Inc. product lines Nov 19, 2019 Fujirebio Europe N.V. announces to have signed a European, exclusive agreement with Atila Biosystems, Inc. for the distribution of the... Read more INNO-LiPA® HPV Genotyping Extra II now CE marked for use on self-collected first-void urine samples Sep 16, 2019 Fujirebio Europe announced today that its genotyping assay for Human Papilloma Virus (HPV), INNO-LiPA HPV Genotyping Extra II received a CE... Read more Fujirebio launches the automated Lumipulse® G AMH assay for accurate assessment of ovarian reserve Apr 26, 2019 Fujirebio Europe announces the release of the Lumipulse G AMH assay for automated quantitative measurement of anti-Müllerian hormone in... Read more Fujirebio expands its INNO-LiPA® CFTR assay portfolio with the launch of INNO-LiPA CFTR Extra Mar 18, 2019 Fujirebio Europe announces the release of the new INNO-LiPA® CFTR Extra assay for the detection of 18 new disease-causing cystic fibrosis... Read more Fujirebio Europe announces the availability of the Lumipulse® G pTau 181 and β-Amyloid 1-40 assays extending its offer of fully automated assays as an aid in the early diagnosis of Alzheimer’s disease Nov 27, 2018 Fujirebio Europe today announced the availability of the Lumipulse G pTau 181 and β-Amyloid 1-40 assays for its fully automated LUMIPULSE G... Read more Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay Jun 12, 2018 Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA)... Read more Load More
CTAD Alzheimer - 12th Clinical Trials on Alzheimer's Disease Dec 4, 2019 - Dec 7, 2019 San Diego, CA , United States More info and meet us there
Fujirebio Europe N.V. signs distribution agreement and extends its molecular product portfolio with the Atila Biosystems, Inc. product lines Nov 19, 2019 Fujirebio Europe N.V. announces to have signed a European, exclusive agreement with Atila Biosystems, Inc. for the distribution of the... Read more
INNO-LiPA® HPV Genotyping Extra II now CE marked for use on self-collected first-void urine samples Sep 16, 2019 Fujirebio Europe announced today that its genotyping assay for Human Papilloma Virus (HPV), INNO-LiPA HPV Genotyping Extra II received a CE... Read more
Fujirebio launches the automated Lumipulse® G AMH assay for accurate assessment of ovarian reserve Apr 26, 2019 Fujirebio Europe announces the release of the Lumipulse G AMH assay for automated quantitative measurement of anti-Müllerian hormone in... Read more
Fujirebio expands its INNO-LiPA® CFTR assay portfolio with the launch of INNO-LiPA CFTR Extra Mar 18, 2019 Fujirebio Europe announces the release of the new INNO-LiPA® CFTR Extra assay for the detection of 18 new disease-causing cystic fibrosis... Read more
Fujirebio Europe announces the availability of the Lumipulse® G pTau 181 and β-Amyloid 1-40 assays extending its offer of fully automated assays as an aid in the early diagnosis of Alzheimer’s disease Nov 27, 2018 Fujirebio Europe today announced the availability of the Lumipulse G pTau 181 and β-Amyloid 1-40 assays for its fully automated LUMIPULSE G... Read more
Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay Jun 12, 2018 Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA)... Read more
